Sugi Predict

Sugi Predict / Compounds / SCHEMBL130392

SCHEMBL130392

SCHEMBL130392

CCOc1cccc(C)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.50
▸ GRM5 P41594 9/20 0.46
▸ BTK Q06187 1/20 0.46
▸ GABRA5 P31644 1/20 0.45
▸ CCR1 P32246 1/20 0.44
▸ CCR8 P51685 1/20 0.44
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ GBA1 P04062 1/20 0.42
▸ NOS3 P29474 1/20 0.41
▸ NOS2 P35228 1/20 0.41
▸ RXRA P19793 1/20 0.39
▸ GRIN1 Q05586 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2525163 0.86 MAPK8 (0.56) MAPK8GRM5BTKGABRA5NPC1
SCHEMBL23126631 0.83 GABRA5 (0.42) MAPK8GRM5BTKGABRA5NPC1
SCHEMBL12093742 0.83 GRM5 (0.48) GRM5GABRA5CCR1CCR8NPC1
SCHEMBL9440370 0.82 LMNA (0.48) GRM5GABRA5CCR1CCR8NPC1
SCHEMBL10544875 0.81 LTA4H (0.52) GRM5NPC1RAB9ASMN1; SMN2TP53
SCHEMBL18137723 0.81 GABRA5 (0.44) MAPK8GRM5GABRA5CCR1CCR8
SCHEMBL15629190 0.81 NOS3 (0.45) MAPK8GRM5GABRA5CCR1CCR8
SCHEMBL27510372 0.81 GABRA5 (0.44) MAPK8GRM5GABRA5CCR1CCR8
SCHEMBL16511922 0.80 BTK (0.65) MAPK8GRM5BTKCCR1CCR8
SCHEMBL28870484 0.79 GABRA5 (0.43) GRM5GABRA5CCR1CCR8NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11771738-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-03 — — US disclosed
US-11771738-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-03 — — US disclosed
WO-2023115149-A1 BIFUNCTIONAL SULPHONAMIDE COMPOUNDS Anaxis Pharma Pty Ltd (AU) 2023-06-29 — — WO disclosed
US-20230136885-A1 SUBSTITUTED 7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES ELI LILLY AND COMPANY 2023-05-04 — — US disclosed
US-20230136885-A1 SUBSTITUTED 7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES ELI LILLY AND COMPANY 2023-05-04 — — US disclosed
WO-2022056447-A1 CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE GENZYME CORPORATION (US) 2022-03-17 — — WO disclosed
WO-2021162944-A1 SUBSTITUTED 7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2021-08-19 — — WO disclosed
US-10954253-B2 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one derivative as Wee1 inhibitor Shijiazhuang Sagacity New Drug Development Co., Ltd. (CN) 2021-03-23 — — US disclosed
EP-3300500-B9 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2021-01-13 — — EP disclosed
EP-3541803-B1 TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-12-23 — — EP disclosed
EP-1608647-B1 5-PHENYLTHIAZOLE DERIVATIVES AND THEIR USE AS P13 KINASE INHIBITORS NOVARTIS AG (CH) 2008-01-09 — — EP disclosed
EP-1857459-A2 Pyrazolopyrimidine compound and a process for preparing the same TANABE SEIYAKU CO., LTD. (JP) 2007-11-21 — — EP disclosed
US-20070191447-A1 Novel heterocyclic compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-08-16 — — US disclosed
US-20070191447-A1 Novel heterocyclic compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-08-16 — — US disclosed
EP-1772454-A1 NITROGENOUS FUSED BICYCLIC COMPOUND TANABE SEIYAKU CO., LTD. (JP) 2007-04-11 — — EP disclosed
EP-1560827-A1 ANTI-INFECTIVE AGENTS Abbott Laboratories (US) 2005-08-10 — — EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 — — US disclosed
US-20040167123-A1 Anti-infective agents ABBVIE INC. 2004-08-26 — — US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 — — US disclosed
WO-2004041818-A1 ANTI-INFECTIVE AGENTS ABBOTT LABORATORIES (US) 2004-05-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191447-A1 Novel heterocyclic compound OPRD1, GRIN3A, GRM3 MAPK8 2015/4885GRM5 83/4885BTK 3154/4885
US-10954253-B2 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one derivative as Wee1 inhibitor WEE1, WEE2, CCNE1 MAPK8 792/4885GRM5 3577/4885BTK 3938/4885
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB MAPK8 2163/4885GRM5 4600/4885BTK 3907/4885
US-20040167123-A1 Anti-infective agents SERPINB1, CYP51A1, ZC3HAV1 MAPK8 2372/4885GRM5 4446/4885BTK 3992/4885
US-11771738-B2 Endoparasitic depsipeptides VIP, PREP, VIPR1 MAPK8 4661/4885GRM5 3074/4885BTK 4521/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT MAPK8 2580/4885GRM5 4387/4885BTK 3711/4885
US-20230136885-A1 SUBSTITUTED 7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES SSB, IL1R1, SLC5A1 MAPK8 291/4885GRM5 2991/4885BTK 541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.